Doxofylline
Form: Tablet & Syrup
Strength: Tab: 200 mg, 400 mg; Syrup: 100 mg/5 mL
Reference Brands: Doxolin®, Respiridox®(India)
Category: Respiratory Disorder
Doxofylline Tablet is a modern bronchodilator used to treat asthma, chronic bronchitis, and COPD. It belongs to the methylxanthine class but offers better tolerability and fewer side effects compared to theophylline. Doxofylline works by relaxing airway muscles, improving airflow, and easing symptoms like wheezing and breathlessness. Commonly available in India in 200 mg and 400 mg strengths, it is sold under trusted brands like Doxolin®, Synasma®, Doxovent®, and Respiridox®. Though not FDA-approved in the US, it is widely prescribed in India and other countries for long-term respiratory management. It is available in tablet and syrup forms.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Fluticasone furoate + Vilanterol
Strength: 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol
Form: Powder For Inhalation(DPI/MDI)
Reference Brands: Breo Ellipta®(US), Relvar Ellipta® (EU)
View Details Get Enquiry
Mometasone + Formoterol
Strength: 100 mcg/5 mcg , 200 mcg/5 mcg
Form: Inhaler(MDI)
Reference Brands: Dulera®(US)
View Details Get Enquiry
Ambroxol Hydrochloride
Strength: Tab: 30 mg, 60 mg; Syrup: 15 mg/5 mL, 30 mg/5 mL; Drops: 7.5 mg/mL, 15 mg/mL
Form: Tablets, Syrup & Oral drops
Reference Brands: Mucosolvan®, Flavamed®, Ambrobeta®, Ambroxol-ratiopharm®(EU)
View Details Get Enquiry
Carbocisteine
Strength: Cap: 375 mg and 750 mg; Oral Solution: 50 mg/5 mL and 750 mg/5 mL
Form: Capsules, Oral Solutions/Syrups
Reference Brands: Mucodyne, Lisomucil®, Rhinathiol®, Muciclar®, Actithiol®, Mucolex®(US)
View Details Get Enquiry